Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

475 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Intensified treatment with high dose rifampicin and levofloxacin compared to standard treatment for adult patients with tuberculous meningitis (TBM-IT): protocol for a randomized controlled trial.
Heemskerk D, Day J, Chau TT, Dung NH, Yen NT, Bang ND, Merson L, Olliaro P, Pouplin T, Caws M, Wolbers M, Farrar J. Heemskerk D, et al. Among authors: olliaro p. Trials. 2011 Feb 2;12:25. doi: 10.1186/1745-6215-12-25. Trials. 2011. PMID: 21288325 Free PMC article. Clinical Trial.
A pivotal registration phase III, multicenter, randomized tuberculosis controlled trial: design issues and lessons learnt from the Gatifloxacin for TB (OFLOTUB) project.
Merle CS, Sismanidis C, Sow OB, Gninafon M, Horton J, Lapujade O, Lo MB, Mitchinson DA, Perronne C, Portaels F, Odhiambo J, Olliaro P, Rustomjee R, Lienhardt C, Fielding K. Merle CS, et al. Among authors: olliaro p. Trials. 2012 May 18;13:61. doi: 10.1186/1745-6215-13-61. Trials. 2012. PMID: 22607233 Free PMC article. Clinical Trial.
An open-label, randomized, non-inferiority trial of the efficacy and safety of ciprofloxacin versus streptomycin + ciprofloxacin in the treatment of bubonic plague (IMASOY): study protocol for a randomized control trial.
Randremanana RV, Raberahona M, Randria MJD, Rajerison M, Andrianaivoarimanana V, Legrand A, Rasoanaivo TF, Randriamparany R, Mayouya-Gamana T, Mangahasimbola R, Bourner J, Salam A, Gillesen A, Edwards T, Schoenhals M, Baril L, Horby P, Olliaro P. Randremanana RV, et al. Among authors: olliaro p. Trials. 2020 Aug 17;21(1):722. doi: 10.1186/s13063-020-04642-2. Trials. 2020. PMID: 32807214 Free PMC article.
Symptom-based case definitions for COVID-19: Time and geographical variations for detection at hospital admission among 260,000 patients.
Baruch J, Rojek A, Kartsonaki C, Vijayaraghavan BKT, Gonçalves BP, Pritchard MG, Merson L, Dunning J, Hall M, Sigfrid L, Citarella BW, Murthy S, Yeabah TO, Olliaro P; ISARIC Clinical Characterisation Group. Baruch J, et al. Among authors: olliaro p. Influenza Other Respir Viruses. 2022 Nov;16(6):1040-1050. doi: 10.1111/irv.13039. Epub 2022 Sep 5. Influenza Other Respir Viruses. 2022. PMID: 36825252 Free PMC article.
In vivo assessment of drug efficacy against Plasmodium falciparum malaria: duration of follow-up.
Stepniewska K, Taylor WR, Mayxay M, Price R, Smithuis F, Guthmann JP, Barnes K, Myint HY, Adjuik M, Olliaro P, Pukrittayakamee S, Looareesuwan S, Hien TT, Farrar J, Nosten F, Day NP, White NJ. Stepniewska K, et al. Among authors: olliaro p. Antimicrob Agents Chemother. 2004 Nov;48(11):4271-80. doi: 10.1128/AAC.48.11.4271-4280.2004. Antimicrob Agents Chemother. 2004. PMID: 15504852 Free PMC article.
Sharing experiences: towards an evidence based model of dengue surveillance and outbreak response in Latin America and Asia.
Badurdeen S, Valladares DB, Farrar J, Gozzer E, Kroeger A, Kuswara N, Ranzinger SR, Tinh HT, Leite P, Mahendradhata Y, Skewes R, Verrall A; European Union, World Health Organization (WHO-TDR) supported IDAMS study group. Badurdeen S, et al. BMC Public Health. 2013 Jun 24;13:607. doi: 10.1186/1471-2458-13-607. BMC Public Health. 2013. PMID: 23800243 Free PMC article.
475 results